Articles written by Gita Karunakaran - Benzinga

Contact Centers Are Increasingly Looking Beyond Traditional Multi-Factor Authentication and Turning To Biometrics To Prevent Fraud

BIO-key International Inc. (NASDAQ: BKYI) is a trusted provider of Identity and Access Management (IAM) and Identity-Bound Biometric solutions that are refining and changing the way Multi-factor Authentication (MFA) is used within IAM.

The Rapidly Expanding World Of Biometrics May Hold Promise In Securing The Future Of Financial Cybersecurity

Biometric systems are gaining immense popularity around the globe. They are easy to use and implement and provide a cost-effective solution for ensuring high-end cybersecurity.

Multi-Factor Authentication – Benefits, Risks, And How You Can Get The Most From It To Ensure Your Organization's Data Is Secure

Cyberattacks are on the rise everywhere today, with organizations and individual account passwords routinely targeted by hackers – especially where accounts are vulnerable due to a lack of additional layers of protection beyond the traditional password itself to help keep them secure.

Precigen Is Pioneering a Nonsurgical Treatment for a Debilitating Respiratory Disease; Positive Data Released on Recurrent Respiratory Papillomatosis Showed a 50% Complete Response

New hope may be on the horizon for sufferers of Recurrent Respiratory Papillomatosis, or RRP, a rare and debilitating disease that typically requires patients to undergo multiple surgeries each year to remove benign tumors called papillomas, that grow in the respiratory tract.

BIO-key's Innovative IAM Solutions Address C-Suite Top Priority – Managing Cyber Risk

In recent times, the potential threats of ransomware and data breaches have been gaining more attention among corporations around the world. Companies are constantly faced with the threat of loss of control over customer data and the adverse impact of an attack on their brand reputation.

How BioStem Plans To Grow Its Perinatal Allografts In 2023 – And Beyond

Florida-based BioStem Technologies, Inc. (OTCMKTS: BSEM) is a biotech company focused on developing and manufacturing structural-tissue allografts derived from perinatal tissues and intended for use as a protective covering for soft-tissue wounds.

Disrupting The Multi-Trillion Dollar Water Market With New Patented Piping Technology Could Be In This Company's Near Future

To invest in Global Composite Piping Solutions LLC and be a part of its growth story, click here.

2022 Year in Review: BioStem Technologies Looks Back At A Year of Growth And Expansion

BioStem Technologies, Inc. (OTCQB: BSEM) is a Florida-based biotechnology company focused on harnessing the natural properties of perinatal tissue in the development, manufacture, and commercialization of structural tissue allografts for use as a protective covering for soft-tissue wounds.

This Company's Rare Cannabinoids May Hold Promise In The Treatment Of Neurodegenerative Diseases Like Alzheimer's

Neurodegenerative diseases such as Parkinson’s, Alzheimer's and others are increasing worldwide as the population ages.

Lithium is the #1 Choice for Most Energy Storage Systems - Could Vanadium Be a Better Alternative?

Interested in investing in StorEn’s campaign? Click here to get started!

Easing Of China's Zero-Covid Policy Could Be Music To The Ears For Investors Looking At Asia

The pandemic brought about a number of challenges to every industry, with the ensuing digital disruption causing a massive shift in the consumer landscape.

Holiday Season Retail Sales Forecasts Are Down – Yoshitsu Could Be Well Placed To Make The Most Of Potentially More Robust Wholesale Trends As Demand Is Pulled Forward

Consumer behavior has changed in many ways since the COVID-19 pandemic hit the world in 2020. One of the key changes was in the way people did their shopping. Most people had to work from home at the time and due to the stay-at-home orders and multiple lockdowns, consumers looked for avenues to shop online and avoid indoor venues like shopping malls and restaurants.

One In Five Americans Could Develop Skin Cancer In Their Lifetime – AiViva's Novel Drug Approach Could Help

Interested in investing in AiViva’s campaign? Click here to get started!

ION Energy May Be Poised To Disrupt The Lithium Supply Market In Asia With Its Presence In Mineral-Rich Mongolia

As the world increasingly moves towards green energy, swapping fossil fuel for emissions-free electrification, batteries are fast becoming a key energy storage mechanism to enable the energy transition.

BioStem Aims To Stay Ahead Of Competition Through Its Unique Processes And Versatile Offerings In Wound Healing

The human body has an amazing ability to heal itself, but the pace and extent of healing can vary dramatically from case to case, depending on the nature of the injury, site and the extent of tissue damage.

Incentives Flowing From Inflation Reduction Act 2022 Could Open Doors For Home Owners And Industrial Units To Invest In Vanadium Batteries

Interested in investing in StorEn’s campaign? Click here to get started!

AiViva Says Its AIV001 Shows Potential Promise To Treat Post-Surgical Incisional Scarring And Keloids

Interested in investing in AiViva’s campaign? Click here to get started!

Planned Government Move To Expand Access To Drugs For End-Stage Renal Disease Patients Could Shine The Spotlight On Unicycive

In the U.S., reimbursement of dialysis expenses by the Centers for Medicare & Medicaid Services (CMS) is done using a prospective payment system (PPS) which enables the payout of a predetermined amount to providers of dialysis services.

Identity-Bound Biometrics Could Eliminate Hidden Costs Of Current Passwordless Solutions, Says BIO-key

With the ever-growing number of websites that individuals need to log into these days, for both work and personal matters, creating and remembering countless, unique, and secure passwords have become a substantial challenge.

This Project Might Give Web3 The Radical Refresh It Desperately Needs

Radix DLT is the world’s first full-stack for DeFi, with the team behind it set on building the foundations for Web3 to truly scale and obsolete traditional finance for good - a feat still to be conquered by those building in the space.